Breast-preserving surgery for tumors of limited size or reduced by neo
adjuvant chemotherapy has definitely entered into the practice. Distan
t results of controlled studies demonstrated that conservative methods
, when correctly indicated and performed, can provide the same results
as mutilating procedures, in terms of overall survival. There is gene
ral agreement on the fact that conservation bears a major risk of intr
abreast recurrences, whose meaning and impact on prognosis are still o
pen to debate. Inadequate surgery, i.e., too-limited excision, or the
lack of radiotherapy, certainly causes a higher rate of local failures
. However, analysis of the patient series reported in the literature p
ermits the conclusion that local failures and distant metastasis are e
vents partially independent of each other. In other words, there are f
actors that are predictive of local recurrence, and not of distant spr
ead, and vice versa, and factors that affect both the risks. Uncertain
ty about the meaning of local recurrences influences therapeutic attit
udes, not only with regard to the choice between total mastectomy and
re-resection, when possible, but also with reference to the identifica
tion of those local recurrences that merit systemic treatment. As far
as the treatment of local failures is concerned, it is too soon to ind
icate undisputable guidelines. It is necessary to wait for distant res
ults of the many experiences in progress on this issue. On the other h
and, since local intrabreast recurrences fortunately are not very freq
uent (about 10% at 10 years from first treatment), the accrual of pati
ents eligible for clinical trials would take a long time, even for coo
perative groups. This is one of the reasons why local failure actually
is an open problem. (C) 1996 Wiley-Liss, Inc.